Tiankang Biotechnology: The net profit attributable to the parent company in the first half of the year was 338 million yuan, a year-on-year increase of 22.27%.

Tiankang Biotech disclosed its semi-annual report on August 29th. The company achieved operating income of 8.847 billion yuan in the first half of the year, a year-on-year increase of 10.68%; net profit attributable to shareholders of the listed company was 338 million yuan, a year-on-year increase of 22.27%; and basic earnings per share were 0.25 yuan.